Global Rapid Acting Insulin Market By Product Type (Insulin Lispro, Insulin Aspart and Insulin Glulisine), By Indication (Type 2 Diabetes and Type 1 Diabetes), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Providers), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027
Published Date : 12-May-2021 |
Pages: 195 |
Formats: PDF |
COVID-19 Impact on the Rapid Acting Insulin Market
Market Overview
The Global Rapid Acting Insulin Market size is expected to reach $11.4 billion by 2027, rising at a market growth of 5.6% CAGR during the forecast period. Rapid-acting insulin is considered as one of the quickest acting insulin that shows the action of working just after the 15 minutes of its application. Insulin’s activation is expected to last for 5 hours. Humalog, Fiasp, NovoRapid, and Apidra are a few of the rapid-acting insulin present in the market.
A rapid-acting insulin is considered as an insulin analog created to mimic meal-induced insulin secretion. These analogs are generally more preferred as compared to the regular insulin due to their rapid response, enabling diabetes patients to consume it intravenously prior to any meal. Advancement in the rapid-acting insulin market is necessary for diabetes management. Though, clinical security and efficacy require the consideration of researchers and experts.
By performing rapid-acting insulin opportunity analysis assessment, higher availability of constant glucose tracking will assist in complex analysis of clinic rapid insulin action which was not earlier feasible. This will assist in knowing whether the latest rapid-acting insulin opportunity analysis will offer a superior degree of optimal glycemic control above HbA1c levels, which is needed for regulatory and scientific compliance.
Along with diabetes, people who have other heart diseases or other complications could maximize the possibility of getting severely ill from COVID-19 as suffering from any above condition makes it more difficult for patients to fight against the infection. This motivated leading companies to deploy unique strategies in order to get a competitive edge during the outbreak of the COVID-19 pandemic.
Product Type Outlook
Based on Product Type, the market is segmented into Insulin Lispro, Insulin Aspart and Insulin Glulisine. On the basis of product type, the insulin lispro segment would exhibit a promising growth rate and procure the highest revenue share in the global rapid-acting insulin market during the forecast period. This is due to the superior benefits offered by the product such as rapid subcutaneous absorption, earlier & higher insulin peak, and short duration of action.
Indication Outlook
Based on Indication, the market is segmented into Type 2 Diabetes and Type 1 Diabetes. On the basis of indication, the type-2 diabetes segment garnered the maximum revenue share of the market, due to the surge in urbanization, unhealthy diet, and low level of physical activity which results in the increasing number of people with type-2 diabetes, thereby propelling the growth of the rapid-acting insulin market.
Distribution Channel Outlook
Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Providers. On the basis of distribution channel, the drug store & retail pharmacies segment procured the biggest revenue share of the market, due to the ubiquitous nature of drug store & retail pharmacy stores. Moreover, these pharmacies offer alternatives for insulin, if there is a non-availability of the prescribed ones.
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 7.8 Billion |
| Market size forecast in 2027 | USD 11.4 Billion |
| Base Year | 2020 |
| Historical Period | 2017 to 2019 |
| Forecast Period | 2021 to 2027 |
| Revenue Growth Rate | CAGR of 5.6% from 2021 to 2027 |
| Number of Pages | 195 |
| Number of Tables | 344 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling, Competitive Landscape |
| Segments covered | Product Type, Indication, Distribution Channel, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Regional Outlook
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America appeared as the leading region in terms of revenue generation in the global rapid-acting insulin market in 2020 and would show a similar trend even during the forecast period. There is a growing case of diabetes and an increasing geriatric population, which is boosting the regional rapid-acting insulin market.
KBV Cardinal Matrix - Rapid Acting Insulin Market Competition Analysis
Free Valuable Insights: Global Rapid Acting Insulin Market size to reach USD 11.4 Billion by 2027
The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Sanofi S.A., Merck & Co., Inc., Novo Nordisk A/S, and Eli Lilly and Company are the forerunners in the Rapid Acting Insulin Market. Companies such as Adocia SA, MannKind Corporation are some of the key innovators in the market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck & Co., Inc., Sanofi S.A., Novo Nordisk A/S, Eli Lilly and Company, Adocia SA, Biocon Limited, Gan & Lee Pharmaceuticals, Geropharm LLC, Wockhardt Ltd., and MannKind Corporation.
Recent Strategies Deployed in Rapid Acting Insulin Market
» Partnerships, Collaborations, and Agreements:
- Oct-2020: Eli Lilly and Company teamed up with DexCom, a company that develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management. Under this collaboration, the companies announced a joint program for U.S. healthcare providers about Lilly's latest rapid-acting mealtime insulin Lyumjev, accessible in U.S. pharmacies, and Dexcom G6 CGM Systems.
- Aug-2019: MannKind Corporation collaborated with One Drop, the world's leading diabetes management platform. This collaboration aimed to offer an effortless experience for Afrezza patients that also includes automatic monitoring of their insulin doses and also other crucial health information on the One Drop platform.
- May-2018: MannKind Corporation signed an exclusive marketing and distribution agreement with Cipla, an Indian multinational pharmaceutical company. In this agreement, Cipla would be responsible for getting regulatory approvals to distribute Afrezza in India that also includes approval from the Drug Controller General of India (DCGI). Cipla would also be responsible for every marketing and sales activity of Afrezza in India.
» Acquisition and Mergers:
- Feb-2021: Merck signed an agreement to acquire Pandion Therapeutics, a biotechnology company. Through this acquisition, Merck’s strategy to detect and safeguard candidates with differentiated & foundational characteristics will be strengthened.
- Dec-2020: MannKind Corporation acquired QrumPharma, a privately held pharmaceutical company. This acquisition aimed to develop a dry powder formulation, which would enable patients having NTM to have a better treatment experience.
» Product Launches and Product Expansion:
- Sep-2020: Novo Nordisk introduced the world's fastest-acting insulin in the Bangladesh market. It is fast-acting insulin, which works four times faster than short-acting human insulin and two times faster than the conventional rapid-acting insulin.
- Apr-2018: Sanofi released its short-acting follow-on insulin lispro product, Admelog. This rapid-acting human insulin analog is indicated to enhance glycemic control in adults and children having diabetes and is accessible in both vials and in a pen presentation.
» Approvals and Trials:
- Mar-2021: Adocia announced the beginning of a Phase 2 study in type 1 diabetes (T1D). This study's aim is to confirm and maximize the security and efficacy of M1Pram as compared to insulin lispro regarding glycemic control and body weight loss.
- Jan-2021: Adocia announced positive results from a clinical pharmacology study comparing BioChaperone (BC) Lispro formulations. It employs insulin lispro from two different sources, the brand, Humalog, from Eli Lilly and a biosimilar from Tonghua Dongbao (THDB).
- Dec-2020: Biocon and Mylan got a positive opinion from the European Medicines Agency's committee for medicinal products for human use (CHMP) recommending approval of the market authorization of their product 'Kixelle'. This product is used for the treatment of type 1 and 2 diabetes.
- Jun-2020: Eli Lilly and Company received approval for Lyumjev from the U.S. Food and Drug Administration (FDA). Lyumjev is the latest rapid-acting insulin indicated to enhance glycemic control in adults, who have type 1 and type 2 diabetes.
- Mar-2020: Novo Nordisk got the approval from the Ministry of Food and Drug Safety for an additional indication for Fiasp. It is an ultrafast-acting insulin aspart injection, which is used to cure children and adolescents. This additional indication from the local drug agency has arisen after the same kind of updated indication in the EU and U.S., based on the ONSET 7 study, in which 777 patients participated including children and adolescents with type-1 diabetes.
- Jan-2020: Eli Lilly and Company received a positive opinion for Lilly's new mealtime insulin from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). This latest mealtime insulin can be used to treat adults having diabetes as part of a numerous daily injection regimen or provided by an insulin pump. It is a novel, fast-acting formulation of insulin lispro, which is analyzed for its usage by adults having type 1 and type 2 diabetes to decrease blood glucose.
- Jun-2019: Adocia initiated a Phase 1b study of ADO09. It is a ready-to-use, certain ratio co-formulation of pramlintide, the only FDA-approved analog of amylin, and A21G human insulin analog, rapid-acting insulin, which is known to be the core circulating metabolite of insulin glargine.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Insulin Lispro
- Insulin Aspart
- Insulin Glulisine
By Indication
- Type 2 Diabetes
- Type 1 Diabetes
By Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Online Providers
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Merck & Co., Inc.
- Sanofi S.A.
- Novo Nordisk A/S
- Eli Lilly and Company
- Adocia SA
- Biocon Limited
- Gan & Lee Pharmaceuticals
- Geropharm LLC
- Wockhardt Ltd.
- MannKind Corporation
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Rapid Acting Insulin Market, by Product Type
1.4.2 Global Rapid Acting Insulin Market, by Indication
1.4.3 Global Rapid Acting Insulin Market, by Distribution Channel
1.4.4 Global Rapid Acting Insulin Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. Global Rapid Acting Insulin Market by Product Type
4.1 Global Insulin Lispro Market by Region
4.2 Global Insulin Aspart Market by Region
4.3 Global Insulin Glulisine Market by Region
Chapter 5. Global Rapid Acting Insulin Market by Indication
5.1 Global Type 2 Diabetes Market by Region
5.2 Global Type 1 Diabetes Market by Region
Chapter 6. Global Rapid Acting Insulin Market by Distribution Channel
6.1 Global Hospital Pharmacies Market by Region
6.2 Global Drug Stores & Retail Pharmacies Market by Region
6.3 Global Online Providers Market by Region
Chapter 7. Global Rapid Acting Insulin Market by Region
7.1 North America Rapid Acting Insulin Market
7.1.1 North America Rapid Acting Insulin Market by Product Type
7.1.1.1 North America Insulin Lispro Market by Country
7.1.1.2 North America Insulin Aspart Market by Country
7.1.1.3 North America Insulin Glulisine Market by Country
7.1.2 North America Rapid Acting Insulin Market by Indication
7.1.2.1 North America Type 2 Diabetes Market by Country
7.1.2.2 North America Type 1 Diabetes Market by Country
7.1.3 North America Rapid Acting Insulin Market by Distribution Channel
7.1.3.1 North America Hospital Pharmacies Market by Country
7.1.3.2 North America Drug Stores & Retail Pharmacies Market by Country
7.1.3.3 North America Online Providers Market by Country
7.1.4 North America Rapid Acting Insulin Market by Country
7.1.4.1 US Rapid Acting Insulin Market
7.1.4.1.1 US Rapid Acting Insulin Market by Product Type
7.1.4.1.2 US Rapid Acting Insulin Market by Indication
7.1.4.1.3 US Rapid Acting Insulin Market by Distribution Channel
7.1.4.2 Canada Rapid Acting Insulin Market
7.1.4.2.1 Canada Rapid Acting Insulin Market by Product Type
7.1.4.2.2 Canada Rapid Acting Insulin Market by Indication
7.1.4.2.3 Canada Rapid Acting Insulin Market by Distribution Channel
7.1.4.3 Mexico Rapid Acting Insulin Market
7.1.4.3.1 Mexico Rapid Acting Insulin Market by Product Type
7.1.4.3.2 Mexico Rapid Acting Insulin Market by Indication
7.1.4.3.3 Mexico Rapid Acting Insulin Market by Distribution Channel
7.1.4.4 Rest of North America Rapid Acting Insulin Market
7.1.4.4.1 Rest of North America Rapid Acting Insulin Market by Product Type
7.1.4.4.2 Rest of North America Rapid Acting Insulin Market by Indication
7.1.4.4.3 Rest of North America Rapid Acting Insulin Market by Distribution Channel
7.2 Europe Rapid Acting Insulin Market
7.2.1 Europe Rapid Acting Insulin Market by Product Type
7.2.1.1 Europe Insulin Lispro Market by Country
7.2.1.2 Europe Insulin Aspart Market by Country
7.2.1.3 Europe Insulin Glulisine Market by Country
7.2.2 Europe Rapid Acting Insulin Market by Indication
7.2.2.1 Europe Type 2 Diabetes Market by Country
7.2.2.2 Europe Type 1 Diabetes Market by Country
7.2.3 Europe Rapid Acting Insulin Market by Distribution Channel
7.2.3.1 Europe Hospital Pharmacies Market by Country
7.2.3.2 Europe Drug Stores & Retail Pharmacies Market by Country
7.2.3.3 Europe Online Providers Market by Country
7.2.4 Europe Rapid Acting Insulin Market by Country
7.2.4.1 Germany Rapid Acting Insulin Market
7.2.4.1.1 Germany Rapid Acting Insulin Market by Product Type
7.2.4.1.2 Germany Rapid Acting Insulin Market by Indication
7.2.5 Germany Rapid Acting Insulin Market by Distribution Channel
7.2.5.1 UK Rapid Acting Insulin Market
7.2.5.1.1 UK Rapid Acting Insulin Market by Product Type
7.2.5.1.2 UK Rapid Acting Insulin Market by Indication
7.2.5.1.3 UK Rapid Acting Insulin Market by Distribution Channel
7.2.5.2 France Rapid Acting Insulin Market
7.2.5.2.1 France Rapid Acting Insulin Market by Product Type
7.2.5.2.2 France Rapid Acting Insulin Market by Indication
7.2.5.2.3 France Rapid Acting Insulin Market by Distribution Channel
7.2.5.3 Russia Rapid Acting Insulin Market
7.2.5.3.1 Russia Rapid Acting Insulin Market by Product Type
7.2.5.4 Russia Rapid Acting Insulin Market by Indication
7.2.5.4.1 Russia Rapid Acting Insulin Market by Distribution Channel
7.2.5.5 Spain Rapid Acting Insulin Market
7.2.5.5.1 Spain Rapid Acting Insulin Market by Product Type
7.2.5.5.2 Spain Rapid Acting Insulin Market by Indication
7.2.5.5.3 Spain Rapid Acting Insulin Market by Distribution Channel
7.2.5.6 Italy Rapid Acting Insulin Market
7.2.5.6.1 Italy Rapid Acting Insulin Market by Product Type
7.2.5.6.2 Italy Rapid Acting Insulin Market by Indication
7.2.5.6.3 Italy Rapid Acting Insulin Market by Distribution Channel
7.2.5.7 Rest of Europe Rapid Acting Insulin Market
7.2.5.7.1 Rest of Europe Rapid Acting Insulin Market by Product Type
7.2.5.7.2 Rest of Europe Rapid Acting Insulin Market by Indication
7.2.5.7.3 Rest of Europe Rapid Acting Insulin Market by Distribution Channel
7.3 Asia Pacific Rapid Acting Insulin Market
7.3.1 Asia Pacific Rapid Acting Insulin Market by Product Type
7.3.1.1 Asia Pacific Insulin Lispro Market by Country
7.3.1.2 Asia Pacific Insulin Aspart Market by Country
7.3.2 Asia Pacific Insulin Glulisine Market by Country
7.3.2.1 Asia Pacific Rapid Acting Insulin Market by Indication
7.3.2.2 Asia Pacific Type 2 Diabetes Market by Country
7.3.2.3 Asia Pacific Type 1 Diabetes Market by Country
7.3.3 Asia Pacific Rapid Acting Insulin Market by Distribution Channel
7.3.3.1 Asia Pacific Hospital Pharmacies Market by Country
7.3.3.2 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
7.3.3.3 Asia Pacific Online Providers Market by Country
7.3.4 Asia Pacific Rapid Acting Insulin Market by Country
7.3.4.1 China Rapid Acting Insulin Market
7.3.4.1.1 China Rapid Acting Insulin Market by Product Type
7.3.4.1.2 China Rapid Acting Insulin Market by Indication
7.3.4.1.3 China Rapid Acting Insulin Market by Distribution Channel
7.3.4.2 Japan Rapid Acting Insulin Market
7.3.4.2.1 Japan Rapid Acting Insulin Market by Product Type
7.3.4.2.2 Japan Rapid Acting Insulin Market by Indication
7.3.4.2.3 Japan Rapid Acting Insulin Market by Distribution Channel
7.3.4.3 India Rapid Acting Insulin Market
7.3.4.3.1 India Rapid Acting Insulin Market by Product Type
7.3.4.3.2 India Rapid Acting Insulin Market by Indication
7.3.4.3.3 India Rapid Acting Insulin Market by Distribution Channel
7.3.4.4 South Korea Rapid Acting Insulin Market
7.3.4.4.1 South Korea Rapid Acting Insulin Market by Product Type
7.3.4.4.2 South Korea Rapid Acting Insulin Market by Indication
7.3.4.4.3 South Korea Rapid Acting Insulin Market by Distribution Channel
7.3.4.5 Singapore Rapid Acting Insulin Market
7.3.4.5.1 Singapore Rapid Acting Insulin Market by Product Type
7.3.4.5.2 Singapore Rapid Acting Insulin Market by Indication
7.3.4.5.3 Singapore Rapid Acting Insulin Market by Distribution Channel
7.3.4.6 Malaysia Rapid Acting Insulin Market
7.3.4.6.1 Malaysia Rapid Acting Insulin Market by Product Type
7.3.4.6.2 Malaysia Rapid Acting Insulin Market by Indication
7.3.4.6.3 Malaysia Rapid Acting Insulin Market by Distribution Channel
7.3.4.7 Rest of Asia Pacific Rapid Acting Insulin Market
7.3.4.7.1 Rest of Asia Pacific Rapid Acting Insulin Market by Product Type
7.3.4.7.2 Rest of Asia Pacific Rapid Acting Insulin Market by Indication
7.3.4.7.3 Rest of Asia Pacific Rapid Acting Insulin Market by Distribution Channel
7.4 LAMEA Rapid Acting Insulin Market
7.4.1 LAMEA Rapid Acting Insulin Market by Product Type
7.4.1.1 LAMEA Insulin Lispro Market by Country
7.4.1.2 LAMEA Insulin Aspart Market by Country
7.4.1.3 LAMEA Insulin Glulisine Market by Country
7.4.2 LAMEA Rapid Acting Insulin Market by Indication
7.4.2.1 LAMEA Type 2 Diabetes Market by Country
7.4.2.2 LAMEA Type 1 Diabetes Market by Country
7.4.3 LAMEA Rapid Acting Insulin Market by Distribution Channel
7.4.3.1 LAMEA Hospital Pharmacies Market by Country
7.4.3.2 LAMEA Drug Stores & Retail Pharmacies Market by Country
7.4.3.3 LAMEA Online Providers Market by Country
7.4.4 LAMEA Rapid Acting Insulin Market by Country
7.4.4.1 Brazil Rapid Acting Insulin Market
7.4.4.1.1 Brazil Rapid Acting Insulin Market by Product Type
7.4.4.1.2 Brazil Rapid Acting Insulin Market by Indication
7.4.4.1.3 Brazil Rapid Acting Insulin Market by Distribution Channel
7.4.4.2 Argentina Rapid Acting Insulin Market
7.4.4.2.1 Argentina Rapid Acting Insulin Market by Product Type
7.4.4.2.2 Argentina Rapid Acting Insulin Market by Indication
7.4.4.2.3 Argentina Rapid Acting Insulin Market by Distribution Channel
7.4.4.3 UAE Rapid Acting Insulin Market
7.4.4.3.1 UAE Rapid Acting Insulin Market by Product Type
7.4.4.3.2 UAE Rapid Acting Insulin Market by Indication
7.4.4.3.3 UAE Rapid Acting Insulin Market by Distribution Channel
7.4.4.4 Saudi Arabia Rapid Acting Insulin Market
7.4.4.4.1 Saudi Arabia Rapid Acting Insulin Market by Product Type
7.4.4.4.2 Saudi Arabia Rapid Acting Insulin Market by Indication
7.4.4.4.3 Saudi Arabia Rapid Acting Insulin Market by Distribution Channel
7.4.4.5 South Africa Rapid Acting Insulin Market
7.4.4.5.1 South Africa Rapid Acting Insulin Market by Product Type
7.4.4.5.2 South Africa Rapid Acting Insulin Market by Indication
7.4.4.5.3 South Africa Rapid Acting Insulin Market by Distribution Channel
7.4.4.6 Nigeria Rapid Acting Insulin Market
7.4.4.6.1 Nigeria Rapid Acting Insulin Market by Product Type
7.4.4.6.2 Nigeria Rapid Acting Insulin Market by Indication
7.4.4.6.3 Nigeria Rapid Acting Insulin Market by Distribution Channel
7.4.4.7 Rest of LAMEA Rapid Acting Insulin Market
7.4.4.7.1 Rest of LAMEA Rapid Acting Insulin Market by Product Type
7.4.4.7.2 Rest of LAMEA Rapid Acting Insulin Market by Indication
7.4.4.7.3 Rest of LAMEA Rapid Acting Insulin Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Merck & Co., Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.2 Sanofi S.A.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Approvals and Trials:
8.3 Novo Nordisk A/S
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental & Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Approvals and Trials:
8.3.5.3 Partnerships, Collaborations, and Agreements:
8.4 Eli Lilly and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Approvals and Trials:
8.4.5.3 Partnerships, Collaborations, and Agreements:
8.5 Adocia SA
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expense
8.5.4 Recent strategies and developments:
8.5.4.1 Approvals and Trials:
8.6 Biocon Limited
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Approvals and Trials:
8.7 Gan & Lee Pharmaceuticals
8.7.1 Company Overview
8.7.2 Financial Analysis
8.8 Geropharm LLC
8.8.1 Company Overview
8.9 Wockhardt Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.10. MannKind Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Research & Development Expense
8.10.4 Recent strategies and developments:
8.10.4.1 Acquisition and Mergers:
8.10.4.2 Partnerships, Collaborations, and Agreements:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Rapid Acting Insulin Market, by Product Type
1.4.2 Global Rapid Acting Insulin Market, by Indication
1.4.3 Global Rapid Acting Insulin Market, by Distribution Channel
1.4.4 Global Rapid Acting Insulin Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. Global Rapid Acting Insulin Market by Product Type
4.1 Global Insulin Lispro Market by Region
4.2 Global Insulin Aspart Market by Region
4.3 Global Insulin Glulisine Market by Region
Chapter 5. Global Rapid Acting Insulin Market by Indication
5.1 Global Type 2 Diabetes Market by Region
5.2 Global Type 1 Diabetes Market by Region
Chapter 6. Global Rapid Acting Insulin Market by Distribution Channel
6.1 Global Hospital Pharmacies Market by Region
6.2 Global Drug Stores & Retail Pharmacies Market by Region
6.3 Global Online Providers Market by Region
Chapter 7. Global Rapid Acting Insulin Market by Region
7.1 North America Rapid Acting Insulin Market
7.1.1 North America Rapid Acting Insulin Market by Product Type
7.1.1.1 North America Insulin Lispro Market by Country
7.1.1.2 North America Insulin Aspart Market by Country
7.1.1.3 North America Insulin Glulisine Market by Country
7.1.2 North America Rapid Acting Insulin Market by Indication
7.1.2.1 North America Type 2 Diabetes Market by Country
7.1.2.2 North America Type 1 Diabetes Market by Country
7.1.3 North America Rapid Acting Insulin Market by Distribution Channel
7.1.3.1 North America Hospital Pharmacies Market by Country
7.1.3.2 North America Drug Stores & Retail Pharmacies Market by Country
7.1.3.3 North America Online Providers Market by Country
7.1.4 North America Rapid Acting Insulin Market by Country
7.1.4.1 US Rapid Acting Insulin Market
7.1.4.1.1 US Rapid Acting Insulin Market by Product Type
7.1.4.1.2 US Rapid Acting Insulin Market by Indication
7.1.4.1.3 US Rapid Acting Insulin Market by Distribution Channel
7.1.4.2 Canada Rapid Acting Insulin Market
7.1.4.2.1 Canada Rapid Acting Insulin Market by Product Type
7.1.4.2.2 Canada Rapid Acting Insulin Market by Indication
7.1.4.2.3 Canada Rapid Acting Insulin Market by Distribution Channel
7.1.4.3 Mexico Rapid Acting Insulin Market
7.1.4.3.1 Mexico Rapid Acting Insulin Market by Product Type
7.1.4.3.2 Mexico Rapid Acting Insulin Market by Indication
7.1.4.3.3 Mexico Rapid Acting Insulin Market by Distribution Channel
7.1.4.4 Rest of North America Rapid Acting Insulin Market
7.1.4.4.1 Rest of North America Rapid Acting Insulin Market by Product Type
7.1.4.4.2 Rest of North America Rapid Acting Insulin Market by Indication
7.1.4.4.3 Rest of North America Rapid Acting Insulin Market by Distribution Channel
7.2 Europe Rapid Acting Insulin Market
7.2.1 Europe Rapid Acting Insulin Market by Product Type
7.2.1.1 Europe Insulin Lispro Market by Country
7.2.1.2 Europe Insulin Aspart Market by Country
7.2.1.3 Europe Insulin Glulisine Market by Country
7.2.2 Europe Rapid Acting Insulin Market by Indication
7.2.2.1 Europe Type 2 Diabetes Market by Country
7.2.2.2 Europe Type 1 Diabetes Market by Country
7.2.3 Europe Rapid Acting Insulin Market by Distribution Channel
7.2.3.1 Europe Hospital Pharmacies Market by Country
7.2.3.2 Europe Drug Stores & Retail Pharmacies Market by Country
7.2.3.3 Europe Online Providers Market by Country
7.2.4 Europe Rapid Acting Insulin Market by Country
7.2.4.1 Germany Rapid Acting Insulin Market
7.2.4.1.1 Germany Rapid Acting Insulin Market by Product Type
7.2.4.1.2 Germany Rapid Acting Insulin Market by Indication
7.2.5 Germany Rapid Acting Insulin Market by Distribution Channel
7.2.5.1 UK Rapid Acting Insulin Market
7.2.5.1.1 UK Rapid Acting Insulin Market by Product Type
7.2.5.1.2 UK Rapid Acting Insulin Market by Indication
7.2.5.1.3 UK Rapid Acting Insulin Market by Distribution Channel
7.2.5.2 France Rapid Acting Insulin Market
7.2.5.2.1 France Rapid Acting Insulin Market by Product Type
7.2.5.2.2 France Rapid Acting Insulin Market by Indication
7.2.5.2.3 France Rapid Acting Insulin Market by Distribution Channel
7.2.5.3 Russia Rapid Acting Insulin Market
7.2.5.3.1 Russia Rapid Acting Insulin Market by Product Type
7.2.5.4 Russia Rapid Acting Insulin Market by Indication
7.2.5.4.1 Russia Rapid Acting Insulin Market by Distribution Channel
7.2.5.5 Spain Rapid Acting Insulin Market
7.2.5.5.1 Spain Rapid Acting Insulin Market by Product Type
7.2.5.5.2 Spain Rapid Acting Insulin Market by Indication
7.2.5.5.3 Spain Rapid Acting Insulin Market by Distribution Channel
7.2.5.6 Italy Rapid Acting Insulin Market
7.2.5.6.1 Italy Rapid Acting Insulin Market by Product Type
7.2.5.6.2 Italy Rapid Acting Insulin Market by Indication
7.2.5.6.3 Italy Rapid Acting Insulin Market by Distribution Channel
7.2.5.7 Rest of Europe Rapid Acting Insulin Market
7.2.5.7.1 Rest of Europe Rapid Acting Insulin Market by Product Type
7.2.5.7.2 Rest of Europe Rapid Acting Insulin Market by Indication
7.2.5.7.3 Rest of Europe Rapid Acting Insulin Market by Distribution Channel
7.3 Asia Pacific Rapid Acting Insulin Market
7.3.1 Asia Pacific Rapid Acting Insulin Market by Product Type
7.3.1.1 Asia Pacific Insulin Lispro Market by Country
7.3.1.2 Asia Pacific Insulin Aspart Market by Country
7.3.2 Asia Pacific Insulin Glulisine Market by Country
7.3.2.1 Asia Pacific Rapid Acting Insulin Market by Indication
7.3.2.2 Asia Pacific Type 2 Diabetes Market by Country
7.3.2.3 Asia Pacific Type 1 Diabetes Market by Country
7.3.3 Asia Pacific Rapid Acting Insulin Market by Distribution Channel
7.3.3.1 Asia Pacific Hospital Pharmacies Market by Country
7.3.3.2 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
7.3.3.3 Asia Pacific Online Providers Market by Country
7.3.4 Asia Pacific Rapid Acting Insulin Market by Country
7.3.4.1 China Rapid Acting Insulin Market
7.3.4.1.1 China Rapid Acting Insulin Market by Product Type
7.3.4.1.2 China Rapid Acting Insulin Market by Indication
7.3.4.1.3 China Rapid Acting Insulin Market by Distribution Channel
7.3.4.2 Japan Rapid Acting Insulin Market
7.3.4.2.1 Japan Rapid Acting Insulin Market by Product Type
7.3.4.2.2 Japan Rapid Acting Insulin Market by Indication
7.3.4.2.3 Japan Rapid Acting Insulin Market by Distribution Channel
7.3.4.3 India Rapid Acting Insulin Market
7.3.4.3.1 India Rapid Acting Insulin Market by Product Type
7.3.4.3.2 India Rapid Acting Insulin Market by Indication
7.3.4.3.3 India Rapid Acting Insulin Market by Distribution Channel
7.3.4.4 South Korea Rapid Acting Insulin Market
7.3.4.4.1 South Korea Rapid Acting Insulin Market by Product Type
7.3.4.4.2 South Korea Rapid Acting Insulin Market by Indication
7.3.4.4.3 South Korea Rapid Acting Insulin Market by Distribution Channel
7.3.4.5 Singapore Rapid Acting Insulin Market
7.3.4.5.1 Singapore Rapid Acting Insulin Market by Product Type
7.3.4.5.2 Singapore Rapid Acting Insulin Market by Indication
7.3.4.5.3 Singapore Rapid Acting Insulin Market by Distribution Channel
7.3.4.6 Malaysia Rapid Acting Insulin Market
7.3.4.6.1 Malaysia Rapid Acting Insulin Market by Product Type
7.3.4.6.2 Malaysia Rapid Acting Insulin Market by Indication
7.3.4.6.3 Malaysia Rapid Acting Insulin Market by Distribution Channel
7.3.4.7 Rest of Asia Pacific Rapid Acting Insulin Market
7.3.4.7.1 Rest of Asia Pacific Rapid Acting Insulin Market by Product Type
7.3.4.7.2 Rest of Asia Pacific Rapid Acting Insulin Market by Indication
7.3.4.7.3 Rest of Asia Pacific Rapid Acting Insulin Market by Distribution Channel
7.4 LAMEA Rapid Acting Insulin Market
7.4.1 LAMEA Rapid Acting Insulin Market by Product Type
7.4.1.1 LAMEA Insulin Lispro Market by Country
7.4.1.2 LAMEA Insulin Aspart Market by Country
7.4.1.3 LAMEA Insulin Glulisine Market by Country
7.4.2 LAMEA Rapid Acting Insulin Market by Indication
7.4.2.1 LAMEA Type 2 Diabetes Market by Country
7.4.2.2 LAMEA Type 1 Diabetes Market by Country
7.4.3 LAMEA Rapid Acting Insulin Market by Distribution Channel
7.4.3.1 LAMEA Hospital Pharmacies Market by Country
7.4.3.2 LAMEA Drug Stores & Retail Pharmacies Market by Country
7.4.3.3 LAMEA Online Providers Market by Country
7.4.4 LAMEA Rapid Acting Insulin Market by Country
7.4.4.1 Brazil Rapid Acting Insulin Market
7.4.4.1.1 Brazil Rapid Acting Insulin Market by Product Type
7.4.4.1.2 Brazil Rapid Acting Insulin Market by Indication
7.4.4.1.3 Brazil Rapid Acting Insulin Market by Distribution Channel
7.4.4.2 Argentina Rapid Acting Insulin Market
7.4.4.2.1 Argentina Rapid Acting Insulin Market by Product Type
7.4.4.2.2 Argentina Rapid Acting Insulin Market by Indication
7.4.4.2.3 Argentina Rapid Acting Insulin Market by Distribution Channel
7.4.4.3 UAE Rapid Acting Insulin Market
7.4.4.3.1 UAE Rapid Acting Insulin Market by Product Type
7.4.4.3.2 UAE Rapid Acting Insulin Market by Indication
7.4.4.3.3 UAE Rapid Acting Insulin Market by Distribution Channel
7.4.4.4 Saudi Arabia Rapid Acting Insulin Market
7.4.4.4.1 Saudi Arabia Rapid Acting Insulin Market by Product Type
7.4.4.4.2 Saudi Arabia Rapid Acting Insulin Market by Indication
7.4.4.4.3 Saudi Arabia Rapid Acting Insulin Market by Distribution Channel
7.4.4.5 South Africa Rapid Acting Insulin Market
7.4.4.5.1 South Africa Rapid Acting Insulin Market by Product Type
7.4.4.5.2 South Africa Rapid Acting Insulin Market by Indication
7.4.4.5.3 South Africa Rapid Acting Insulin Market by Distribution Channel
7.4.4.6 Nigeria Rapid Acting Insulin Market
7.4.4.6.1 Nigeria Rapid Acting Insulin Market by Product Type
7.4.4.6.2 Nigeria Rapid Acting Insulin Market by Indication
7.4.4.6.3 Nigeria Rapid Acting Insulin Market by Distribution Channel
7.4.4.7 Rest of LAMEA Rapid Acting Insulin Market
7.4.4.7.1 Rest of LAMEA Rapid Acting Insulin Market by Product Type
7.4.4.7.2 Rest of LAMEA Rapid Acting Insulin Market by Indication
7.4.4.7.3 Rest of LAMEA Rapid Acting Insulin Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Merck & Co., Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.2 Sanofi S.A.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Approvals and Trials:
8.3 Novo Nordisk A/S
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental & Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Approvals and Trials:
8.3.5.3 Partnerships, Collaborations, and Agreements:
8.4 Eli Lilly and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Approvals and Trials:
8.4.5.3 Partnerships, Collaborations, and Agreements:
8.5 Adocia SA
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expense
8.5.4 Recent strategies and developments:
8.5.4.1 Approvals and Trials:
8.6 Biocon Limited
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Approvals and Trials:
8.7 Gan & Lee Pharmaceuticals
8.7.1 Company Overview
8.7.2 Financial Analysis
8.8 Geropharm LLC
8.8.1 Company Overview
8.9 Wockhardt Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.10. MannKind Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Research & Development Expense
8.10.4 Recent strategies and developments:
8.10.4.1 Acquisition and Mergers:
8.10.4.2 Partnerships, Collaborations, and Agreements:
List of Tables
TABLE 1 Global Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 2 Global Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Rapid Acting Insulin Market]
TABLE 4 Product Launches And Product Expansions– Rapid Acting Insulin Market
TABLE 5 Acquisition and Mergers– Rapid Acting Insulin Market
TABLE 6 Approvals and Trials– Rapid Acting Insulin Market
TABLE 7 Global Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 8 Global Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 9 Global Insulin Lispro Market by Region, 2017 - 2020, USD Million
TABLE 10 Global Insulin Lispro Market by Region, 2021 - 2027, USD Million
TABLE 11 Global Insulin Aspart Market by Region, 2017 - 2020, USD Million
TABLE 12 Global Insulin Aspart Market by Region, 2021 - 2027, USD Million
TABLE 13 Global Insulin Glulisine Market by Region, 2017 - 2020, USD Million
TABLE 14 Global Insulin Glulisine Market by Region, 2021 - 2027, USD Million
TABLE 15 Global Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 16 Global Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 17 Global Type 2 Diabetes Market by Region, 2017 - 2020, USD Million
TABLE 18 Global Type 2 Diabetes Market by Region, 2021 - 2027, USD Million
TABLE 19 Global Type 1 Diabetes Market by Region, 2017 - 2020, USD Million
TABLE 20 Global Type 1 Diabetes Market by Region, 2021 - 2027, USD Million
TABLE 21 Global Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 22 Global Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 23 Global Hospital Pharmacies Market by Region, 2017 - 2020, USD Million
TABLE 24 Global Hospital Pharmacies Market by Region, 2021 - 2027, USD Million
TABLE 25 Global Drug Stores & Retail Pharmacies Market by Region, 2017 - 2020, USD Million
TABLE 26 Global Drug Stores & Retail Pharmacies Market by Region, 2021 - 2027, USD Million
TABLE 27 Global Online Providers Market by Region, 2017 - 2020, USD Million
TABLE 28 Global Online Providers Market by Region, 2021 - 2027, USD Million
TABLE 29 Global Rapid Acting Insulin Market by Region, 2017 - 2020, USD Million
TABLE 30 Global Rapid Acting Insulin Market by Region, 2021 - 2027, USD Million
TABLE 31 North America Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 32 North America Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 33 North America Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 34 North America Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 35 North America Insulin Lispro Market by Country, 2017 - 2020, USD Million
TABLE 36 North America Insulin Lispro Market by Country, 2021 - 2027, USD Million
TABLE 37 North America Insulin Aspart Market by Country, 2017 - 2020, USD Million
TABLE 38 North America Insulin Aspart Market by Country, 2021 - 2027, USD Million
TABLE 39 North America Insulin Glulisine Market by Country, 2017 - 2020, USD Million
TABLE 40 North America Insulin Glulisine Market by Country, 2021 - 2027, USD Million
TABLE 41 North America Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 42 North America Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 43 North America Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 44 North America Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 45 North America Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 46 North America Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 47 North America Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 48 North America Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 49 North America Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 50 North America Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 51 North America Drug Stores & Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 52 North America Drug Stores & Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 53 North America Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 54 North America Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 55 North America Rapid Acting Insulin Market by Country, 2017 - 2020, USD Million
TABLE 56 North America Rapid Acting Insulin Market by Country, 2021 - 2027, USD Million
TABLE 57 US Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 58 US Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 59 US Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 60 US Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 61 US Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 62 US Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 63 US Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 64 US Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 65 Canada Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 66 Canada Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 67 Canada Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 68 Canada Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 69 Canada Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 70 Canada Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 71 Canada Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 72 Canada Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 73 Mexico Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 74 Mexico Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 75 Mexico Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 76 Mexico Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 77 Mexico Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 78 Mexico Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 79 Mexico Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 80 Mexico Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 81 Rest of North America Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 82 Rest of North America Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 83 Rest of North America Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 84 Rest of North America Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 85 Rest of North America Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 86 Rest of North America Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 87 Rest of North America Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 88 Rest of North America Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 89 Europe Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 90 Europe Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 91 Europe Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 92 Europe Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 93 Europe Insulin Lispro Market by Country, 2017 - 2020, USD Million
TABLE 94 Europe Insulin Lispro Market by Country, 2021 - 2027, USD Million
TABLE 95 Europe Insulin Aspart Market by Country, 2017 - 2020, USD Million
TABLE 96 Europe Insulin Aspart Market by Country, 2021 - 2027, USD Million
TABLE 97 Europe Insulin Glulisine Market by Country, 2017 - 2020, USD Million
TABLE 98 Europe Insulin Glulisine Market by Country, 2021 - 2027, USD Million
TABLE 99 Europe Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 100 Europe Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 101 Europe Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 102 Europe Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 103 Europe Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 104 Europe Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 105 Europe Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 106 Europe Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 107 Europe Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 108 Europe Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 109 Europe Drug Stores & Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 110 Europe Drug Stores & Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 111 Europe Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 112 Europe Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 113 Europe Rapid Acting Insulin Market by Country, 2017 - 2020, USD Million
TABLE 114 Europe Rapid Acting Insulin Market by Country, 2021 - 2027, USD Million
TABLE 115 Germany Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 116 Germany Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 117 Germany Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 118 Germany Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 119 Germany Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 120 Germany Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 121 Germany Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 122 Germany Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 123 UK Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 124 UK Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 125 UK Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 126 UK Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 127 UK Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 128 UK Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 129 UK Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 130 UK Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 131 France Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 132 France Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 133 France Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 134 France Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 135 France Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 136 France Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 137 France Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 138 France Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 139 Russia Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 140 Russia Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 141 Russia Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 142 Russia Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 143 Russia Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 144 Russia Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 145 Russia Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 146 Russia Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 147 Spain Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 148 Spain Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 149 Spain Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 150 Spain Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 151 Spain Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 152 Spain Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 153 Spain Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 154 Spain Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 155 Italy Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 156 Italy Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 157 Italy Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 158 Italy Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 159 Italy Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 160 Italy Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 161 Italy Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 162 Italy Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 163 Rest of Europe Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 164 Rest of Europe Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 165 Rest of Europe Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 166 Rest of Europe Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 167 Rest of Europe Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 168 Rest of Europe Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 169 Rest of Europe Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 170 Rest of Europe Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 171 Asia Pacific Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 172 Asia Pacific Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 173 Asia Pacific Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 174 Asia Pacific Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 175 Asia Pacific Insulin Lispro Market by Country, 2017 - 2020, USD Million
TABLE 176 Asia Pacific Insulin Lispro Market by Country, 2021 - 2027, USD Million
TABLE 177 Asia Pacific Insulin Aspart Market by Country, 2017 - 2020, USD Million
TABLE 178 Asia Pacific Insulin Aspart Market by Country, 2021 - 2027, USD Million
TABLE 179 Asia Pacific Insulin Glulisine Market by Country, 2017 - 2020, USD Million
TABLE 180 Asia Pacific Insulin Glulisine Market by Country, 2021 - 2027, USD Million
TABLE 181 Asia Pacific Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 182 Asia Pacific Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 183 Asia Pacific Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 184 Asia Pacific Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 185 Asia Pacific Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 186 Asia Pacific Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 187 Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 188 Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 189 Asia Pacific Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 190 Asia Pacific Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 191 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 192 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 193 Asia Pacific Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 194 Asia Pacific Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 195 Asia Pacific Rapid Acting Insulin Market by Country, 2017 - 2020, USD Million
TABLE 196 Asia Pacific Rapid Acting Insulin Market by Country, 2021 - 2027, USD Million
TABLE 197 China Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 198 China Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 199 China Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 200 China Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 201 China Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 202 China Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 203 China Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 204 China Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 205 Japan Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 206 Japan Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 207 Japan Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 208 Japan Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 209 Japan Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 210 Japan Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 211 Japan Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 212 Japan Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 213 India Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 214 India Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 215 India Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 216 India Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 217 India Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 218 India Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 219 India Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 220 India Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 221 South Korea Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 222 South Korea Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 223 South Korea Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 224 South Korea Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 225 South Korea Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 226 South Korea Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 227 South Korea Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 228 South Korea Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 229 Singapore Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 230 Singapore Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 231 Singapore Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 232 Singapore Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 233 Singapore Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 234 Singapore Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 235 Singapore Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 236 Singapore Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 237 Malaysia Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 238 Malaysia Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 239 Malaysia Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 240 Malaysia Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 241 Malaysia Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 242 Malaysia Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 243 Malaysia Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 244 Malaysia Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 245 Rest of Asia Pacific Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 246 Rest of Asia Pacific Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 247 Rest of Asia Pacific Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 248 Rest of Asia Pacific Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 249 Rest of Asia Pacific Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 250 Rest of Asia Pacific Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 251 Rest of Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 252 Rest of Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 253 LAMEA Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 254 LAMEA Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 255 LAMEA Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 256 LAMEA Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 257 LAMEA Insulin Lispro Market by Country, 2017 - 2020, USD Million
TABLE 258 LAMEA Insulin Lispro Market by Country, 2021 - 2027, USD Million
TABLE 259 LAMEA Insulin Aspart Market by Country, 2017 - 2020, USD Million
TABLE 260 LAMEA Insulin Aspart Market by Country, 2021 - 2027, USD Million
TABLE 261 LAMEA Insulin Glulisine Market by Country, 2017 - 2020, USD Million
TABLE 262 LAMEA Insulin Glulisine Market by Country, 2021 - 2027, USD Million
TABLE 263 LAMEA Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 264 LAMEA Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 265 LAMEA Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 266 LAMEA Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 267 LAMEA Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 268 LAMEA Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 269 LAMEA Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 270 LAMEA Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 271 LAMEA Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 272 LAMEA Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 273 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 274 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 275 LAMEA Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 276 LAMEA Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 277 LAMEA Rapid Acting Insulin Market by Country, 2017 - 2020, USD Million
TABLE 278 LAMEA Rapid Acting Insulin Market by Country, 2021 - 2027, USD Million
TABLE 279 Brazil Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 280 Brazil Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 281 Brazil Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 282 Brazil Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 283 Brazil Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 284 Brazil Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 285 Brazil Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 286 Brazil Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 287 Argentina Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 288 Argentina Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 289 Argentina Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 290 Argentina Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 291 Argentina Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 292 Argentina Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 293 Argentina Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 294 Argentina Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 295 UAE Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 296 UAE Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 297 UAE Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 298 UAE Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 299 UAE Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 300 UAE Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 301 UAE Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 302 UAE Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 303 Saudi Arabia Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 304 Saudi Arabia Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 305 Saudi Arabia Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 306 Saudi Arabia Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 307 Saudi Arabia Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 308 Saudi Arabia Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 309 Saudi Arabia Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 310 Saudi Arabia Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 311 South Africa Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 312 South Africa Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 313 South Africa Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 314 South Africa Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 315 South Africa Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 316 South Africa Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 317 South Africa Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 318 South Africa Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 319 Nigeria Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 320 Nigeria Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 321 Nigeria Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 322 Nigeria Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 323 Nigeria Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 324 Nigeria Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 325 Nigeria Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 326 Nigeria Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 327 Rest of LAMEA Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 328 Rest of LAMEA Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 329 Rest of LAMEA Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 330 Rest of LAMEA Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 331 Rest of LAMEA Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 332 Rest of LAMEA Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 333 Rest of LAMEA Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 334 Rest of LAMEA Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 335 key information - Merck & Co., Inc.
TABLE 336 Key Information – Sanofi S.A.
TABLE 337 Key information – Novo Nordisk A/S
TABLE 338 Key Information – Eli Lilly and Company
TABLE 339 key information – Adocia SA
TABLE 340 Key Information – Biocon Limited
TABLE 341 Key Information – Gan & Lee Pharmaceuticals
TABLE 342 key Information – Geropharm LLC
TABLE 343 Key Information – Wockhardt Ltd.
TABLE 344 Key Information – MannKind Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Recent strategies and developments: Novo Nordisk A/S
FIG 5 Recent strategies and developments: Eli Lilly and Company
FIG 6 Recent strategies and developments: MannKind Corporation
TABLE 2 Global Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Rapid Acting Insulin Market]
TABLE 4 Product Launches And Product Expansions– Rapid Acting Insulin Market
TABLE 5 Acquisition and Mergers– Rapid Acting Insulin Market
TABLE 6 Approvals and Trials– Rapid Acting Insulin Market
TABLE 7 Global Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 8 Global Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 9 Global Insulin Lispro Market by Region, 2017 - 2020, USD Million
TABLE 10 Global Insulin Lispro Market by Region, 2021 - 2027, USD Million
TABLE 11 Global Insulin Aspart Market by Region, 2017 - 2020, USD Million
TABLE 12 Global Insulin Aspart Market by Region, 2021 - 2027, USD Million
TABLE 13 Global Insulin Glulisine Market by Region, 2017 - 2020, USD Million
TABLE 14 Global Insulin Glulisine Market by Region, 2021 - 2027, USD Million
TABLE 15 Global Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 16 Global Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 17 Global Type 2 Diabetes Market by Region, 2017 - 2020, USD Million
TABLE 18 Global Type 2 Diabetes Market by Region, 2021 - 2027, USD Million
TABLE 19 Global Type 1 Diabetes Market by Region, 2017 - 2020, USD Million
TABLE 20 Global Type 1 Diabetes Market by Region, 2021 - 2027, USD Million
TABLE 21 Global Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 22 Global Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 23 Global Hospital Pharmacies Market by Region, 2017 - 2020, USD Million
TABLE 24 Global Hospital Pharmacies Market by Region, 2021 - 2027, USD Million
TABLE 25 Global Drug Stores & Retail Pharmacies Market by Region, 2017 - 2020, USD Million
TABLE 26 Global Drug Stores & Retail Pharmacies Market by Region, 2021 - 2027, USD Million
TABLE 27 Global Online Providers Market by Region, 2017 - 2020, USD Million
TABLE 28 Global Online Providers Market by Region, 2021 - 2027, USD Million
TABLE 29 Global Rapid Acting Insulin Market by Region, 2017 - 2020, USD Million
TABLE 30 Global Rapid Acting Insulin Market by Region, 2021 - 2027, USD Million
TABLE 31 North America Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 32 North America Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 33 North America Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 34 North America Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 35 North America Insulin Lispro Market by Country, 2017 - 2020, USD Million
TABLE 36 North America Insulin Lispro Market by Country, 2021 - 2027, USD Million
TABLE 37 North America Insulin Aspart Market by Country, 2017 - 2020, USD Million
TABLE 38 North America Insulin Aspart Market by Country, 2021 - 2027, USD Million
TABLE 39 North America Insulin Glulisine Market by Country, 2017 - 2020, USD Million
TABLE 40 North America Insulin Glulisine Market by Country, 2021 - 2027, USD Million
TABLE 41 North America Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 42 North America Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 43 North America Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 44 North America Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 45 North America Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 46 North America Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 47 North America Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 48 North America Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 49 North America Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 50 North America Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 51 North America Drug Stores & Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 52 North America Drug Stores & Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 53 North America Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 54 North America Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 55 North America Rapid Acting Insulin Market by Country, 2017 - 2020, USD Million
TABLE 56 North America Rapid Acting Insulin Market by Country, 2021 - 2027, USD Million
TABLE 57 US Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 58 US Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 59 US Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 60 US Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 61 US Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 62 US Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 63 US Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 64 US Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 65 Canada Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 66 Canada Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 67 Canada Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 68 Canada Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 69 Canada Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 70 Canada Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 71 Canada Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 72 Canada Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 73 Mexico Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 74 Mexico Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 75 Mexico Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 76 Mexico Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 77 Mexico Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 78 Mexico Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 79 Mexico Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 80 Mexico Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 81 Rest of North America Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 82 Rest of North America Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 83 Rest of North America Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 84 Rest of North America Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 85 Rest of North America Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 86 Rest of North America Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 87 Rest of North America Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 88 Rest of North America Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 89 Europe Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 90 Europe Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 91 Europe Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 92 Europe Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 93 Europe Insulin Lispro Market by Country, 2017 - 2020, USD Million
TABLE 94 Europe Insulin Lispro Market by Country, 2021 - 2027, USD Million
TABLE 95 Europe Insulin Aspart Market by Country, 2017 - 2020, USD Million
TABLE 96 Europe Insulin Aspart Market by Country, 2021 - 2027, USD Million
TABLE 97 Europe Insulin Glulisine Market by Country, 2017 - 2020, USD Million
TABLE 98 Europe Insulin Glulisine Market by Country, 2021 - 2027, USD Million
TABLE 99 Europe Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 100 Europe Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 101 Europe Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 102 Europe Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 103 Europe Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 104 Europe Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 105 Europe Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 106 Europe Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 107 Europe Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 108 Europe Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 109 Europe Drug Stores & Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 110 Europe Drug Stores & Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 111 Europe Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 112 Europe Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 113 Europe Rapid Acting Insulin Market by Country, 2017 - 2020, USD Million
TABLE 114 Europe Rapid Acting Insulin Market by Country, 2021 - 2027, USD Million
TABLE 115 Germany Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 116 Germany Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 117 Germany Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 118 Germany Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 119 Germany Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 120 Germany Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 121 Germany Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 122 Germany Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 123 UK Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 124 UK Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 125 UK Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 126 UK Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 127 UK Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 128 UK Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 129 UK Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 130 UK Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 131 France Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 132 France Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 133 France Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 134 France Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 135 France Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 136 France Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 137 France Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 138 France Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 139 Russia Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 140 Russia Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 141 Russia Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 142 Russia Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 143 Russia Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 144 Russia Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 145 Russia Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 146 Russia Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 147 Spain Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 148 Spain Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 149 Spain Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 150 Spain Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 151 Spain Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 152 Spain Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 153 Spain Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 154 Spain Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 155 Italy Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 156 Italy Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 157 Italy Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 158 Italy Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 159 Italy Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 160 Italy Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 161 Italy Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 162 Italy Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 163 Rest of Europe Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 164 Rest of Europe Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 165 Rest of Europe Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 166 Rest of Europe Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 167 Rest of Europe Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 168 Rest of Europe Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 169 Rest of Europe Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 170 Rest of Europe Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 171 Asia Pacific Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 172 Asia Pacific Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 173 Asia Pacific Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 174 Asia Pacific Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 175 Asia Pacific Insulin Lispro Market by Country, 2017 - 2020, USD Million
TABLE 176 Asia Pacific Insulin Lispro Market by Country, 2021 - 2027, USD Million
TABLE 177 Asia Pacific Insulin Aspart Market by Country, 2017 - 2020, USD Million
TABLE 178 Asia Pacific Insulin Aspart Market by Country, 2021 - 2027, USD Million
TABLE 179 Asia Pacific Insulin Glulisine Market by Country, 2017 - 2020, USD Million
TABLE 180 Asia Pacific Insulin Glulisine Market by Country, 2021 - 2027, USD Million
TABLE 181 Asia Pacific Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 182 Asia Pacific Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 183 Asia Pacific Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 184 Asia Pacific Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 185 Asia Pacific Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 186 Asia Pacific Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 187 Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 188 Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 189 Asia Pacific Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 190 Asia Pacific Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 191 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 192 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 193 Asia Pacific Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 194 Asia Pacific Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 195 Asia Pacific Rapid Acting Insulin Market by Country, 2017 - 2020, USD Million
TABLE 196 Asia Pacific Rapid Acting Insulin Market by Country, 2021 - 2027, USD Million
TABLE 197 China Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 198 China Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 199 China Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 200 China Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 201 China Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 202 China Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 203 China Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 204 China Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 205 Japan Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 206 Japan Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 207 Japan Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 208 Japan Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 209 Japan Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 210 Japan Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 211 Japan Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 212 Japan Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 213 India Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 214 India Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 215 India Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 216 India Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 217 India Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 218 India Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 219 India Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 220 India Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 221 South Korea Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 222 South Korea Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 223 South Korea Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 224 South Korea Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 225 South Korea Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 226 South Korea Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 227 South Korea Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 228 South Korea Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 229 Singapore Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 230 Singapore Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 231 Singapore Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 232 Singapore Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 233 Singapore Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 234 Singapore Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 235 Singapore Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 236 Singapore Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 237 Malaysia Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 238 Malaysia Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 239 Malaysia Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 240 Malaysia Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 241 Malaysia Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 242 Malaysia Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 243 Malaysia Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 244 Malaysia Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 245 Rest of Asia Pacific Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 246 Rest of Asia Pacific Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 247 Rest of Asia Pacific Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 248 Rest of Asia Pacific Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 249 Rest of Asia Pacific Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 250 Rest of Asia Pacific Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 251 Rest of Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 252 Rest of Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 253 LAMEA Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 254 LAMEA Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 255 LAMEA Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 256 LAMEA Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 257 LAMEA Insulin Lispro Market by Country, 2017 - 2020, USD Million
TABLE 258 LAMEA Insulin Lispro Market by Country, 2021 - 2027, USD Million
TABLE 259 LAMEA Insulin Aspart Market by Country, 2017 - 2020, USD Million
TABLE 260 LAMEA Insulin Aspart Market by Country, 2021 - 2027, USD Million
TABLE 261 LAMEA Insulin Glulisine Market by Country, 2017 - 2020, USD Million
TABLE 262 LAMEA Insulin Glulisine Market by Country, 2021 - 2027, USD Million
TABLE 263 LAMEA Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 264 LAMEA Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 265 LAMEA Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 266 LAMEA Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 267 LAMEA Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 268 LAMEA Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 269 LAMEA Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 270 LAMEA Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 271 LAMEA Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 272 LAMEA Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 273 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 274 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 275 LAMEA Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 276 LAMEA Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 277 LAMEA Rapid Acting Insulin Market by Country, 2017 - 2020, USD Million
TABLE 278 LAMEA Rapid Acting Insulin Market by Country, 2021 - 2027, USD Million
TABLE 279 Brazil Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 280 Brazil Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 281 Brazil Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 282 Brazil Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 283 Brazil Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 284 Brazil Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 285 Brazil Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 286 Brazil Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 287 Argentina Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 288 Argentina Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 289 Argentina Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 290 Argentina Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 291 Argentina Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 292 Argentina Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 293 Argentina Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 294 Argentina Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 295 UAE Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 296 UAE Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 297 UAE Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 298 UAE Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 299 UAE Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 300 UAE Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 301 UAE Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 302 UAE Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 303 Saudi Arabia Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 304 Saudi Arabia Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 305 Saudi Arabia Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 306 Saudi Arabia Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 307 Saudi Arabia Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 308 Saudi Arabia Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 309 Saudi Arabia Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 310 Saudi Arabia Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 311 South Africa Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 312 South Africa Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 313 South Africa Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 314 South Africa Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 315 South Africa Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 316 South Africa Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 317 South Africa Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 318 South Africa Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 319 Nigeria Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 320 Nigeria Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 321 Nigeria Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 322 Nigeria Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 323 Nigeria Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 324 Nigeria Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 325 Nigeria Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 326 Nigeria Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 327 Rest of LAMEA Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 328 Rest of LAMEA Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 329 Rest of LAMEA Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 330 Rest of LAMEA Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 331 Rest of LAMEA Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 332 Rest of LAMEA Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 333 Rest of LAMEA Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 334 Rest of LAMEA Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 335 key information - Merck & Co., Inc.
TABLE 336 Key Information – Sanofi S.A.
TABLE 337 Key information – Novo Nordisk A/S
TABLE 338 Key Information – Eli Lilly and Company
TABLE 339 key information – Adocia SA
TABLE 340 Key Information – Biocon Limited
TABLE 341 Key Information – Gan & Lee Pharmaceuticals
TABLE 342 key Information – Geropharm LLC
TABLE 343 Key Information – Wockhardt Ltd.
TABLE 344 Key Information – MannKind Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Recent strategies and developments: Novo Nordisk A/S
FIG 5 Recent strategies and developments: Eli Lilly and Company
FIG 6 Recent strategies and developments: MannKind Corporation